Abstract:Rho‐related BTB domain containing protein 1 (RhoBTB1) is a novel transcriptional target of peroxisome proliferator activated receptor gamma (PPARγ). In a GWAS study of over 1 million subjects, RhoBTB1 was identified as an interacting locus for hypertension. However, the physiological and molecular function of RhoBTB1 is not well‐understood. Previous studies suggest that RhoBTB1 in vascular smooth muscle cells (VSMC) mediates the anti‐hypertensive effect of PPARγ. RhoBTB1 expression was decreased in aortas from mice expressing smooth muscle specific dominant negative PPARγ mutation. Genetic complementation of smooth muscle RhoBTB1 reverses the hypertension, vascular dysfunction and arterial stiffness caused by dominant negative PPARγ mutation. In HEK293 cells, RhoBTB1 interacts with phosphodiesterase 5 (PDE5) and increases PDE5 ubiquitination in a Cullin‐3 dependent manner, suggesting that RhoBTB1 might function as a substrate adaptor for Cullin‐3‐RING ubiquitin ligase and mediate PDE5 turn over.RhoBTB1 expression was also decreased in aortas from mice treated with angiotensin II (Ang‐II, 490ng/kg/min, two weeks). We hypothesized that restoration of VSMC RhoBTB1 will reverse Ang‐II mediated hypertension, vascular dysfunction and arterial stiffness. We treated transgenic mice expressing inducible VSMC specific RhoBTB1 (S‐RhoBTB1 mice) with Ang‐II (490ng/kg/min, six weeks) and activated the transgene with Tamoxifen injections during the third week of Ang‐II infusion. ISM‐Cre mice expressing smooth muscle specific Cre‐recombinase were also treated with Ang‐II and Tamoxifen to serve as control. Blood pressure was measured by radiotelemetry. Ang‐II increased blood pressure in both ISM‐Cre and S‐RhoBTB1 mice to a similar extent. Thus, Ang‐II induced hypertension was not affected by RhoBTB1 transgene expression in VSMC. Carotid artery vasodilation response to acetylcholine and sodium nitroprusside, as well as vasoconstriction response to KCl, serotonin and endothelin‐1 were tested using wire myography. No differences were found in these measures of vascular function between S‐RhoBTB1 mice and ISM‐Cre mice. Arterial stiffness was assessed by pulse wave velocity (PWV). Ang‐II infusion increased PWV to a similar level in ISM‐Cre and S‐RhoBTB1 mice before the transgene induction. PWV of S‐RhoBTB1 mice started to decrease after Tamoxifen whereas PWV of ISM‐Cre mice continued to increase. By the second week after Tamoxifen, RhoBTB1 transgene expression in VSMC significantly attenuated Ang‐II mediated arterial stiffness (ISM‐Cre vs. S‐RhoBTB1 4.21±0.37 vs. 3.17±0.16 mm/ms, p=0.02, n=7–9). This data suggests a potential mechanism where RhoBTB1 improves vascular plasticity independently from blood pressure and is protective against arterial stiffness.Support or Funding InformationNIH R35 HL144807AHA 20PRE35120137

DP1 (Prostaglandin D2 Receptor 1) Activation Protects Against Vascular Remodeling and Vascular Smooth Muscle Cell Transition to Myofibroblasts in Angiotensin II–Induced Hypertension in Mice

Dectin-1 Acts As a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling.

Abstract 394: Chronic Knockdown of the NTS AT1R Increases Circulating Inflammatory-Endothelial Progenitor Cells Ratio and Exacerbates Hypertension in the SHR

Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension Via Mtorc1 Signaling

Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway

Vascular smooth muscle cells specific deletion of angiopoietin-like protein 8 prevents angiotensin II-promoted hypertension and cardiovascular hypertrophy

Abstract 374: Smooth Muscle Cell-specific Deletion Of At1a Receptor Attenuates Vascular Fibrosis In Angiotensin Ii-infused Mice

Inhibition of Histone Demethylase JMJD1C Attenuates Cardiac Hypertrophy and Fibrosis Induced by Angiotensin II

The Role of Vascular Smooth Muscle RhoBTB1 in Hypertension

Microsomal Prostaglandin Synthase-1-Derived Prostaglandin E-2 Protects Against Angiotensin Ii-Induced Hypertension Via Inhibition of Oxidative Stress

Enhanced Pressor Response to Acute Ang II Infusion in Mice Lacking Membrane-Associated Prostaglandin E2 Synthase-1.

The ADP Antagonist MRS2179 Regulates the Phenotype of Smooth Muscle Cells to Limit Intimal Hyperplasia

Prostaglandin E1 Attenuates AngII-induced Cardiac Hypertrophy Via EP3 Receptor Activation and Netrin-1upregulation

Andrographolide Promotes Interaction Between Endothelin-Dependent EDNRA/EDNRB and Myocardin-SRF to Regulate Pathological Vascular Remodeling

Endothelial Cell-Specific Prolyl Hydroxylase-2 Deficiency Augments Angiotensin II-Induced Arterial Stiffness and Cardiac Pericyte Recruitment in Mice

Abstract 124: RhoBTB1, a Novel PPARγ Target Gene, Rescues Hypertension and Vascular Dysfunction Caused by PPARγ Dysfunction

Peroxisome Proliferator-Activated Receptor α Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Angiotensin II-Induced ROS Production

Angiotensin II-induced Matrix Metalloproteinase-8 is Regulated by Angiotensin-(1-7) in Vascular Smooth Muscle Cells

DP1 Activation Reverses Age-Related Hypertension via NEDD4L-Mediated T-bet Degradation in T Cells

Stromal Cell-Derived Factor-1 Exerts Opposing Roles Through CXCR4 and CXCR7 in Angiotensin II-induced Adventitial Remodeling.

Inactivation of the E-prostanoid 3 Receptor Attenuates the Angiotensin II Pressor Response Via Decreasing Arterial Contractility.